Skip to content
★ Sign in to follow
AB

Aron B. Anderson

Surmodics Inc
Total declarations
19
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (5 ops.)
€377k

Latest filing published 17 Nov 2009 for Surmodics INC, €68k.

Insider track record

Disclosed buys
0
Disclosed sells
5
Signal history

No signal scores available.

Aron B. Anderson: trading record in brief

Aron B. Anderson discloses dealings in Surmodics Inc to SEC (Form 4). Between 21 March 2006 and 17 November 2009, the trades on record add up to 19 filings.

Every open-market trade on record is a sale: 5 sales worth €377k. Besides market trades, the filings include 10 share grants and 3 option exercises. 2009 to date brings no purchases and 1 sale.

On 17 November 2009 came the latest disclosure, an open-market sale for €68k in Surmodics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Aron B. Anderson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total
  • ▼
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    101,218 USD0SEC
    4,320 shares@ US$23.43Common StockSEC:0001209191-09-053295:0
  • ◆
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    0SEC
    1,701 shares0Common StockSEC:0001209191-08-061708:0
  • ◆
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    13,483 USD0SEC
    556 shares@ US$24.25Common StockSEC:0001209191-08-061708:1
  • ◇
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    87,125 USD0SEC
    2,500 shares@ US$34.85Common StockSEC:0001209191-08-031006:0
  • ▼
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    71,875 USD0SEC
    1,638 shares@ US$43.88Common StockSEC:0001209191-08-029151:0
  • ▼
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    8,778 USD0SEC
    200 shares@ US$43.89Common StockSEC:0001209191-08-029151:1
  • ●
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    0SEC
    400 shares0Common StockSEC:0001209191-07-063983:0
  • ◆
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    0SEC
    8,000 shares0Common StockSEC:0001209191-07-063983:1
  • ▼
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    172,800 USD0SEC
    3,600 shares@ US$48.00Common StockSEC:0000914190-07-000478:0
  • ◇
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    87,815 USD0SEC
    3,500 shares@ US$25.09Common StockSEC:0000914190-07-000468:0
  • ▼
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    175,000 USD0SEC
    3,500 shares@ US$50.00Common StockSEC:0000914190-07-000468:1
  • ◆
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    24,556 USD0SEC
    661 shares@ US$37.15Common StockSEC:0000914190-07-000190:0
  • ◆
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    0SEC
    1,250 shares0Common StockSEC:0000914190-06-000614:0
  • ◆
    VP & Chief Scientific OfficerExecutivesSurmodics Inc
    0SEC
    5,000 shares0Common StockSEC:0000914190-06-000141:0

14 of 14 declarations